Suppr超能文献

伊朗伊斯法罕先天性甲状腺功能减退症患者的甲状腺过氧化物酶基因突变。

Thyroid peroxidase gene mutation in patients with congenital hypothyroidism in isfahan, iran.

机构信息

Isfahan Endocrine and Metabolism Research Center, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

Int J Endocrinol. 2012;2012:717283. doi: 10.1155/2012/717283. Epub 2012 Aug 2.

Abstract

Background. Thyroid peroxidase gene (TPO) mutations are one of the most common causes of thyroid dyshormonogenesis in patients with congenital hypothyroidism (CH). In this study, the prevalence of TPO gene mutations in patients with thyroid dyshormonogenesis in Isfahan was investigated. Methods. In this cross-sectional study, genomic DNA of 41 patients with permanent CH due to thyroid dyshormonogenesis was extracted using the salting out method. The 17 exonic regions of the TPO gene were amplified. SSCP technique was performed for scanning of the exonic regions of the TPO gene, except exon 8. DNA sequencing was performed for those with different migration patterns in SSCP by chain termination method. Exon 8 was sequenced directly in all patients. In 4 patients, all fragments were also sequenced. Results. One missense mutation c.2669G > A (NM_000547.5) at exon 15 (14th coding exon) in one patient in homozygous form and seven different single nucleotide polymorphisms (SNPs) in exons 1, 7, 8, 11, and 15 of TPO gene. Conclusion. The TPO gene mutations among CH patients with dyshormonogenesis in Isfahan were less frequent in comparison with other similar studies. It may be due to the presence of other unknown gene mutations which could not be detected by SSCP and sequencing methods.

摘要

背景

甲状腺过氧化物酶基因(TPO)突变是先天性甲状腺功能减退症(CH)患者甲状腺激素生成障碍的最常见原因之一。本研究旨在调查伊斯法罕地区甲状腺激素生成障碍患者中 TPO 基因突变的流行情况。

方法

在这项横断面研究中,采用盐析法提取 41 例甲状腺激素生成障碍导致的永久性 CH 患者的基因组 DNA。扩增 TPO 基因的 17 个外显子区域。采用 SSCP 技术对 TPO 基因的外显子区域(除 8 号外显子)进行扫描,对 SSCP 中出现不同迁移模式的样本采用链终止法进行 DNA 测序。对所有患者的 8 号外显子进行直接测序。对 4 例患者的所有片段也进行了测序。

结果

在 1 例患者中发现了杂合形式的 TPO 基因 15 号外显子 c.2669G > A(NM_000547.5)错义突变,以及 TPO 基因 1、7、8、11 和 15 号外显子中的 7 种不同的单核苷酸多态性(SNP)。

结论

与其他类似研究相比,伊斯法罕地区 CH 患者中甲状腺激素生成障碍患者的 TPO 基因突变频率较低。这可能是由于存在其他未知基因突变,这些突变无法通过 SSCP 和测序方法检测到。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27a9/3419406/4c46e9a656cf/IJE2012-717283.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验